Ketamine and Benzodiazepines: What to Know Before Therapy

Can You Take Ketamine While Taking Benzodiazepines?

Yes, if a licensed clinician determines it is medically appropriate. In most cases, that decision depends on your full clinical picture.

A benzodiazepine is a prescription sedative used for anxiety, panic, or sleep. Common ones include alprazolam (Xanax), lorazepam (Ativan), clonazepam (Klonopin), and diazepam (Valium). If you take one, you can often still be considered for ketamine therapy once a provider reviews your full picture.

The decision is conditional for two reasons:

• Effectiveness: benzodiazepines may reduce or slow ketamine's antidepressant benefit, mainly at higher doses.¹
• Safety: ketamine and benzodiazepines are both CNS depressants, so together they can add to sedation.⁴

Mindbloom's screening treats benzodiazepine use as a factor to review, not an automatic disqualifier. The FDA labels list it as an interaction requiring monitoring, not a contraindication.⁴ Benzodiazepines do need to be disclosed and reviewed, which is why combining benzodiazepines with ketamine is treated as part of eligibility screening rather than a fixed barrier.

Two questions decide how this plays out for you: will it still work, and is it safe? Start with effectiveness.

Do Benzodiazepines Make Ketamine Less Effective?

They might, mainly at higher doses, but the evidence is limited and mixed. The concern is that a benzodiazepine could soften or shorten ketamine's antidepressant effect. Here is what the research actually shows.

A 2023 analysis of the RAPID intravenous ketamine study found that simply being on a benzodiazepine did not change the overall antidepressant response.¹ Instead, the effect differed by dose. The authors reported: "concomitant oral benzodiazepines at higher doses may attenuate the antidepressant effects of IV ketamine at day 1 but not day 3 post-infusion."¹

A 2021 systematic review in the International Journal of Neuropsychopharmacology reached a more cautious conclusion.² The review found that "benzodiazepines were repeatedly shown to reduce the duration of ketamine's antidepressant effect."²

The same authors rated the overall quality of this evidence as low. So the finding is a signal, not a settled fact.

One point matters for interpreting all of this. Every study here used IV (intravenous) racemic ketamine. Mindbloom's treatment uses sublingual tablets and subcutaneous injections, and there are no direct interaction studies for those routes.

So for most people, the honest read is this: a benzodiazepine may make ketamine somewhat less effective, especially at higher doses. It usually is not a reason to avoid treatment. It is a reason to plan treatment with your provider.

How much you take appears to matter more than whether you take one at all.¹ Mindbloom studies its own real-world outcomes under supervised care, which helps put questions about response in context.

Does Your Benzodiazepine Dose Matter?

Dose appears to matter more than use alone. A 2020 study in Frontiers in Psychiatry linked a higher benzodiazepine dose to a weaker response in IV ketamine.³ The threshold sat above 8 milligrams of diazepam-equivalent, a common scale for comparing benzodiazepines on one measure.

That study reported "a sensitivity of 80% and a specificity of 84.6%" for telling responders from nonresponders at that cutoff.³

The two studies do not agree on timing, and it is worth being clear about that. Andrashko and colleagues found the weaker response at days 3 and 7 after treatment.³ The Feeney analysis cited earlier found an effect at day 1 only.¹

The timing of any attenuation is unsettled. There is also a confounder to keep in mind. People taking benzodiazepines often started with more severe anxiety, and higher baseline anxiety can independently blunt response.

That makes it hard to separate the medication's effect from the condition it treats. This threshold describes the benzodiazepine dose, not ketamine's own dosing. Understanding why benzodiazepines may do this makes the dose pattern easier to follow.

Why Benzodiazepines Interfere: GABA and Glutamate

The likely reason comes down to two opposing brain signals. Glutamate is the brain's main excitatory, or "go," signal. GABA (gamma-aminobutyric acid) is the main inhibitory, or "slow down," signal.

Ketamine temporarily increases glutamate signaling. Researchers think this surge drives the neuroplasticity, the brain's ability to form new connections, behind ketamine's benefits.⁷ You can read more about the glutamate and neuroplasticity science that supports this idea.

Benzodiazepines increase GABA activity, which can quiet that same glutamate surge.² That is the leading hypothesis for why a benzodiazepine could soften ketamine's effect. It is a working theory, not a proven certainty.

One clarification helps here. Ketamine is not a benzodiazepine, and it is not simply a sedative. It is an NMDA-receptor antagonist, a medicine that acts on part of the brain's glutamate system.

That is a different mechanism from how ketamine differs from benzodiazepines that work through GABA. Effectiveness is only half the question. The other half is physical safety.

Is It Safe to Combine Ketamine and Benzodiazepines?

Under medical supervision, the combination is managed, but it does carry a real mechanism worth understanding. Both ketamine and benzodiazepines are central nervous system (CNS) depressants, meaning they slow activity in the brain and nervous system. When you take two at once, their calming effects can add together.

Most often that shows up as extra drowsiness. At higher or unsupervised doses, added CNS depression can also slow breathing.

The ketamine FDA prescribing label is explicit. It states that combining ketamine with benzodiazepines or other CNS depressants "may result in profound sedation, respiratory depression, coma, and death."⁴ That language is on the label for anesthetic and high-dose intravenous or intramuscular use, so the most severe outcomes reflect that setting. At the lower doses used in supervised therapy, the practical concern is added sedation, which is why same-day benzodiazepine use is held.

The FDA esketamine label also advises providers to closely monitor for sedation when it is used with CNS depressants such as benzodiazepines.⁵

In Mindbloom's peer-reviewed Journal of Affective Disorders study of 11,441 Mindbloom clients treated with the Mindbloom sublingual ketamine protocol, serious adverse events occurred in 6 patients, or 0.05%.⁶ This is a real-world observational safety finding. Individual results may vary.

You can review Mindbloom's study summary for the full peer-reviewed detail.

The takeaway is not that the combination is risk-free. It is that screening, supervision, and defined protocols are what keep additive sedation in check. Unsupervised combining, outside of a clinician's plan, is the real hazard.

You can see the full ketamine side effect profile for context on what is common and what is rare. One benzodiazepine comes up more than any other, so it is worth a closer look.

Ketamine and Xanax (Alprazolam)

Taking ketamine with Xanax is possible only under medical oversight, not on your own. Xanax is a brand name for alprazolam, a benzodiazepine, so the general benzodiazepine picture applies to it directly.

Because alprazolam is a benzodiazepine, the FDA label noted earlier applies to it directly. That warning covers combining ketamine with benzodiazepines or other CNS depressants, which can add sedation and, at higher doses, slow breathing.⁴

The practical meaning is oversight, not avoidance. If you and your prescriber decide to proceed, timing is the next practical question.

How to Time Benzodiazepines Around a Ketamine Session

There is no single universal number, because the right timing depends on your specific benzodiazepine, your dose, and your clinician's judgment. Short-acting benzodiazepines clear the body faster, while longer-acting ones linger, so the plan is personalized rather than one-size-fits-all. Holding benzodiazepines before dosing is common across ketamine clinics, not only a Mindbloom practice. The current interdisciplinary standard for IV ketamine, the ASKP3 2026 Delphi consensus, reached agreement on 73 of 75 practice items, though it addresses IV ketamine rather than at-home sublingual or subcutaneous care.⁸

As a matter of program policy, Mindbloom advises clients to refrain from benzodiazepines for 24 hours before treatment. The aim is to avoid adding sedation or softening the experience. This is part of Mindbloom's timing psychiatric medications safely guidance, not a universal industry rule.

One safety rule is firm. Never stop or reduce a benzodiazepine on your own, because abrupt changes can trigger withdrawal effects. Any change is planned and supervised by your prescriber.

Benzodiazepines are not the only thing worth reviewing before treatment.

Other Medications and Substances to Review Before Ketamine Therapy

Several other medications and substances deserve a look before you begin, so your provider has the full picture. The list below is a quick reference, not a substitute for a complete interaction check with your provider. The additive CNS-depressant effect noted above applies to several of the entries here.

• Alcohol and other sedatives: add to ketamine's depressant effects, as the FDA label noted earlier describes, and are best avoided around sessions.⁴
• Opioids: can add sedation and, at higher doses, slow breathing, consistent with that same FDA label warning, so disclose all use.⁴
• Stimulants such as Adderall: may raise blood pressure and heart rate, which ketamine can also do temporarily.
• MAOIs: carry blood-pressure considerations your provider will weigh during screening.
• Gabapentin and trazodone: can add to sedation, usually a timing and monitoring conversation, not a barrier.
• SSRIs and SNRIs: generally continued under clinician guidance, not typically a reason to stop treatment.

Each of these is a general interaction class, not a personalized instruction. Your provider decides what applies to you. All of this comes together in one place: the conversation with your provider.

Working With Your Provider on an Individualized Plan

The most useful step you can take is full disclosure. Tell your provider about every prescription, over-the-counter drug, supplement, and substance you use, including your benzodiazepine dose and how often you take it. That information lets a provider decide whether to proceed, how to time your medications, and how to monitor you during and after a session.

Combining ketamine and benzodiazepines is one of several interactions your provider reviews. The FDA label noted earlier advises clinicians to "closely monitor neurological status and respiratory parameters, including respiratory rate and pulse oximetry."⁴ Mindbloom's sessions are medically supervised, which puts that kind of monitoring into practice.

Mindbloom is one example of how this works. Its intake includes clinician consults and a comprehensive medical evaluation that reviews your current medications. Care is individualized to your history and goals rather than run from a fixed template.

The purchase sequence is straightforward. You choose a program of 6, 12, or 18 sessions first, based on your goals and budget. After you select a program, a licensed provider conducts a medical evaluation to confirm your candidacy and eligibility screening and to personalize your plan.

From there, oversight continues through treatment. You can review how sessions are supervised to see how provider involvement, screening, and support come together.

If a benzodiazepine is part of your life, this is the process that turns the research above into a plan built for you. Quick answers to the questions people ask most follow below.